两种治疗2型糖尿病联合用药方案的费用-效果分析  

Analysis on treatment cost-effect of type 2 diabetes in two combination schemes

作　　者：樊玉霞 

机构地区：[1]北京广内社区卫生服务中心,北京100053

出　　处：《中国医药导报》2011年第32期138-139,共2页China Medical Herald

摘　　要：目的:探讨两种常用的联合用药方案对2型糖尿病的治疗效果和经济效果。方法:选择2型糖尿病患者100例,随机分为A、B两组,每组50例,分别运用混人胰岛素联合阿卡波糖和阿卡波糖联合二甲双胍进行治疗,并对其进行费用-效果分析。结果:A组的总有效率为86%,B组的有效率为92%,两种治疗方案具有相似的临床疗效,但阿卡波糖联合二甲双胍治疗方案的费用为235.48元,明显低于应用混人胰岛素联合阿卡波糖治疗方案的费用(389.10元),差异具有统计学意义(P<0.05),更具有经济学价值。结论:从药物经济学考虑,两种方案中阿卡波糖联合二甲双胍治疗方案在社区治疗2型糖尿病中更为理想,值得推广。Objective： To discuss the treatment effect-economic effect by using two combination schemes for type 2 diabetes. Methods： 100 patients with type 2 diabetes were selected and randomly divided into group A and group B, each group had 50 cases. Two groups were respectively used mixed human insulin jointed with Acarbose and Acarbose jointed with Metformin to treat type 2 diabetes. Treatment cost-effect were analysed. Results： The total effective rate of group A was 86%, total effective rate of group B was 92%, two treatment programs had similar clinical efficacy, the cost of Acarbose jointed with Mefformin was 235.48 yaan, which was significantly lower than the cost of mixed human insulin jointed with Acarbose （389.10 yuan）. There was a statistically significant difference （P〈0.05）, and had more economic value. Conclusion： Acarbose jointed with Metformin to treat type 2 diabetes is worthy to application in the community with its ideal effect from consideration of the drug economics.

关 键 词：2型糖尿病 社区 费用-效果分析 

分 类 号：R587.1[医药卫生—内分泌]